89 related articles for article (PubMed ID: 26344931)
1. SOX2 expression inhibits terminal epidermal differentiation.
Chen Y; Sen GL
Exp Dermatol; 2015 Dec; 24(12):974-6. PubMed ID: 26344931
[No Abstract] [Full Text] [Related]
2. KLF4 suppresses the tumor activity of cutaneous squamous cell carcinoma (SCC) cells via the regulation of SMAD signaling and SOX2 expression.
Li XM; Kim SJ; Hong DK; Jung KE; Choi CW; Seo YJ; Lee JH; Lee Y; Kim CD
Biochem Biophys Res Commun; 2019 Sep; 516(4):1110-1115. PubMed ID: 31284949
[TBL] [Abstract][Full Text] [Related]
3. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
4. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma.
Siegle JM; Basin A; Sastre-Perona A; Yonekubo Y; Brown J; Sennett R; Rendl M; Tsirigos A; Carucci JA; Schober M
Nat Commun; 2014 Jul; 5():4511. PubMed ID: 25077433
[TBL] [Abstract][Full Text] [Related]
5. Translation from unconventional 5' start sites drives tumour initiation.
Sendoel A; Dunn JG; Rodriguez EH; Naik S; Gomez NC; Hurwitz B; Levorse J; Dill BD; Schramek D; Molina H; Weissman JS; Fuchs E
Nature; 2017 Jan; 541(7638):494-499. PubMed ID: 28077873
[TBL] [Abstract][Full Text] [Related]
6. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
[TBL] [Abstract][Full Text] [Related]
7. Immunocyto- and histochemical profiling of nucleostemin expression: marker of epidermal stem cells?
Lacina L; Smetana K; Dvoránková B; Stork J; Plzáková Z; Gabius HJ
J Dermatol Sci; 2006 Nov; 44(2):73-80. PubMed ID: 17000083
[TBL] [Abstract][Full Text] [Related]
8. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
9. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
10. SOX2 and squamous cancers.
Porter L; McCaughan F
Semin Cancer Biol; 2020 Dec; 67(Pt 1):154-167. PubMed ID: 32905832
[TBL] [Abstract][Full Text] [Related]
11. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.
Ruchusatsawat K; Wongpiyabovorn J; Protjaroen P; Chaipipat M; Shuangshoti S; Thorner PS; Mutirangura A
Hum Pathol; 2011 Dec; 42(12):1878-87. PubMed ID: 21663940
[TBL] [Abstract][Full Text] [Related]
12. Role of integrins in regulating epidermal adhesion, growth and differentiation.
Watt FM
EMBO J; 2002 Aug; 21(15):3919-26. PubMed ID: 12145193
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Long Noncoding RNA SMRT-2 Controls Epidermal Differentiation.
Lee CS; Mah A; Aros CJ; Lopez-Pajares V; Bhaduri A; Webster DE; Kretz M; Khavari PA
J Invest Dermatol; 2018 Jun; 138(6):1445-1449. PubMed ID: 29360484
[No Abstract] [Full Text] [Related]
14. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
15. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.
Vitale-Cross L; Amornphimoltham P; Fisher G; Molinolo AA; Gutkind JS
Cancer Res; 2004 Dec; 64(24):8804-7. PubMed ID: 15604235
[TBL] [Abstract][Full Text] [Related]
16. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
Hussenet T; du Manoir S
Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
[TBL] [Abstract][Full Text] [Related]
17. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
[TBL] [Abstract][Full Text] [Related]
18. Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.
Ishitsuka Y; Kawachi Y; Taguchi S; Maruyama H; Nakamura Y; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
Exp Dermatol; 2013 May; 22(5):318-22. PubMed ID: 23489647
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
20. S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA-3/caspase-14 pathway in A431 cells.
Li T; Qi Z; Kong F; Li Y; Wang R; Zhang W; Shang Y; Huang L; He D; Xiao X
Exp Dermatol; 2015 May; 24(5):342-8. PubMed ID: 25651379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
